Work

Nivolumab (Nivolumab BMS®) for the second-line therapy of metastatic squamous non-small cell lung cancer

Year: 2015

Type: article

Authors: A. Nachtnebel, M. Ujeyl

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1223033725

FWCI:

Cites:

Cited by:

Related to: 10